AE is primarily associated with Type I hypersensitivity reactions, involving the release of histamine and other chemicals from mast cells and basophils, or with deficiencies or dysfunctions of the C1 Inhibitor (C1INH), leading to uncontrolled release of bradykinin [1, 2]. This evidence concerns the gene SERPING1 and IgE responsiveness, atopic.